reports
- Arnaud Riverain
MGI (ALMDG) - Résultats S1 : Solide mais incertitude à court terme/ Ac...
CA S1 : 27,1 M€, +15,8% (+1,5% pc) Apport d’Altix : 3,3 M€, +7% International : 97%du CA, +15,9% Part du réseau Konica Minolta : 19 M€, +8% Marge brute stable à 68,3% Marge d’Ebitda 14,3% vs 18% (19,5% hors Altix) / Mex 2,7% vs 8% (8,9% hors Altix) / Marge nette 9,1% vs 10,9% (13,5% hors Altix) Gearing -12,6% vs -16,5% au 31/12/24
- Nicholas Cortellucci
- CFA
Cantech Investment Conference: Research Booklet
We are teaming up with Cantech to publish Company Spotlight reports on the companies presenting at its conference on October 9th in Toronto. The reports aim to serve as an introduction to each company and provide a basic investment thesis. To learn more about the conference and sign up to attend, please check it out here. Companies Mentioned: Acceleware Limited Anaergia Inc. Argo Corporation Avante Corp. Baylin Technologies Inc. BeWhere Holdings Inc. BIGG Digital Assets Inc. BQE Water Inc. Cl...
BYL BAYLIN TECHNOLOGIES INC
DGI. DATA COMMUNICATIONS MANAGEMENT
YFI EDGEWATER WIRELESS SYSTEMS
ENW ENWAVE CORP.
FTG FIRAN TECHNOLOGY GROUP CORP.
STAR STAR SANITARYWARE
XX AVANTE LOGIXX
PTOTF PATRIOT ONE TECHNOLOGIES
BIGG BIGG DIGITAL ASSET
ANRG ANAERGIA INC
HITI HIGH TIDE INC
GRID TANTALUS SYSTEMS HLDG INC
AIDX HEALWELL AI INC
BQE BQE WATER INC.
SBIO SABIO HOLDINGS
TTGI INC. (SBIO)
VOL TURNIUM TECHNOLOGY GROUP INC.
MGRO VOLATUS AEROSPACE CORP
TRBE MUSTGROW BIOLOGICS CORP
TRIBE PROPERTY TECHNOLOGIES INC. (TRBE)
- Arnaud Riverain
- Arnaud Riverain
MGI (ALMDG) - Initiation de couverture : L'innovation "encrée" / Achat...
MGI Digital Technology s’est imposé comme un acteur de référence dans le domaine de l’impression numérique à valeur ajoutée, avec une spécialisation dans les finitions haut de gamme (vernis, dorure, personnalisation à la demande).
Claranova: 1 director
A director at Claranova sold 32,072 shares at 1.317EUR and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
- Guy Sips
- Hilde Van Boxstael
- Thomas Vranken
- Wim Lewi
- Guy Sips
- Hilde Van Boxstael
- Lynn Hautekeete
- Thomas Vranken
- Wim Hoste
- Wim Lewi
Mithra postpones its annual general meeting
Mithra postpones its annual general meeting Liege, Belgium, 28 May 2024 – 15:00 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that in the context of the monetization process and the uncertainties related thereto, Mithra postpones its Annual General Shareholders’ Meeting, , to a later date to be determined. Background Information: Mithra announced the launch of a comprehensive monetization process, exploring potential sales of selected assets, notably Estetra SRL, and potentially the entire business. Additionally, Mithra announced the en...
- Hilde Van Boxstael
- Michiel Declercq
- Thomas Couvreur
- Thomas Vranken
- Wim Hoste
- Wim Lewi
Mithra enters into exclusive negotiations with Gedeon Richter and secu...
Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the context of its monetization process Liege, Belgium, 3 May 2024 – 17:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that, after diligent evaluation of , Mithra has selected the offer submitted by Gedeon Richter, which relates to Estetra SRL, Neuralis SA and specific assets held by Mithra R&D SA related to the E4 platform, as a basis for further negotiations and decided to grant exclusivity to Gedeon Richter for the purpose of such negotiation...
Mithra updates on offers received in the context of its monetization p...
Mithra updates on offers received in the context of its monetization process and on its Annual Report 2023 Mithra has received binding offers for selected assets, including Estetra SRL, as part of its monetization process. As it stands, the aggregate amount of these offers is insufficient to ensure full repayment of all creditors of Mithra, and, therefore, the offers do not allow to create value for Mithra’s shareholders at the present time.Mithra has requested the suspension of trading of its shares on Euronext Brussels pending continuing negotiations with offering parties.Mithra postpones...
Mithra secures court protection measures to advance monetization proce...
Mithra secures court protection measures to advance monetization process Court Grants "Transfer under Judicial Supervision" for CDMO facility, safeguarding Mithra's activities and expediting the M&A process for its Contract Development and Manufacturing Organization.Approval of Judicial Reorganization Proceedings for Novalon SA, facilitating an amicable agreement with some creditors and restructuring the debt of Mithra's complex therapeutics business.Mithra Advances Monetization Process with Court Protection Measures, marking significant milestones in the company's commitment to maximizing ...
- Jacob Mekhael
- Thibault Leneeuw
- Thomas Vranken
- Hilde Van Boxstael
- Jacob Mekhael
- Kristof Samoy
- Lynn Hautekeete
- Sharad Kumar S.P
- Thibault Leneeuw
- Thomas Vranken
- Wim Hoste
- Wim Lewi
- Guy Sips
- Hilde Van Boxstael
- Jacob Mekhael
- Thomas Vranken
- Wim Hoste
- Wim Lewi
- Thomas Vranken
Mithra FY23: better than expected operations, but cash and liabilities...
Mithra's FY23 results reveal € 40m revenues and € -48m REBITDA somewhat higher than our expectations, although a € 74m impairment on the CMO and Zoreline tanks the net loss to € 173.5m. While the monetisation process for (parts of) the business is ongoing, we estimate that little value could be left for shareholders. We therefore adopt a Sell rating (previously Reduce) and decrease our TP from € 1.0 to € 0.1.
- Guy Sips
- Jacob Mekhael
- Thibault Leneeuw
- Thomas Vranken
- Thomas Vranken
- Guy Sips
- Hilde Van Boxstael
- Kristof Samoy
- Thomas Couvreur
- Thomas Vranken
- Wim Hoste
- Wim Lewi
- Hilde Van Boxstael
- Kristof Samoy
- Michiel Declercq
- Thomas Couvreur
- Thomas Vranken
- Wim Lewi
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.